John O’Mullane

861 citations
28 papers · 589 indexed · h-index 16

John O’Mullane

28 papers receiving 558 citations

Peers

John O’Mullane
Comparison fields: 5 of 128
  • Obstetrics and Gynecology 48
  • Pharmaceutical Science 37
  • Health 47
  • Biomaterials 72
  • Surfaces, Coatings and Films 31
Replace Panpan Wang with:
Panpan Wang China
Aihua Wu Australia
Marzieh Azizi Iran
Luca Di Giampaolo Italy
Yuanyuan Wang China
Ventola Cl United States
Ganna Chornokur United States
Ali Aliabadi Iran
Seo‐Young Park South Korea
M.A. Pessi Italy
John O’Mullane relative to Panpan Wang China Panpan Wang's profile →
Citations per field
00.5×6.2×
Panpan Wang · 1×
Citations per year

Countries citing papers authored by John O’Mullane

Since Specialization
Citations

This map shows the geographic impact of John O’Mullane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John O’Mullane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John O’Mullane more than expected).

Fields of papers citing papers by John O’Mullane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John O’Mullane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John O’Mullane. The network helps show where John O’Mullane may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John O’Mullane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John O’Mullane Line = papers co-authored together John O’Mullane links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20226
2 201816
3 201618
4 201313
5 20131
6 201246
7 201239
8 201243
9 201243
10 201120
11 200036
12 199936
13 19982
14 19915
15 19916
16 199014
17 19894
18 198823
19 198729
20 198225

About John O’Mullane

John O’Mullane is a scholar working on Pharmaceutical Science, Biomaterials and Obstetrics and Gynecology, having authored 28 papers that have together received 589 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (4 papers), Lipid Membrane Structure and Behavior (4 papers), Advanced Drug Delivery Systems (3 papers), Pregnancy and preeclampsia studies (2 papers), Lipoproteins and Cardiovascular Health (2 papers), Health Literacy and Information Accessibility (2 papers), Misinformation and Its Impacts (2 papers) and Inhalation and Respiratory Drug Delivery (2 papers). The work is most often cited by research in Obstetrics and Gynecology (48 citations), Pharmaceutical Science (37 citations) and Health (47 citations). John O’Mullane has collaborated with scholars based in Ireland, Switzerland and United States. Frequent co-authors include Karel Petrak, E. Tomlinson, Keelin O’Donoghue, Peter Goddard, L Brookman, Caroline Joyce, David Murphy, H. P. Redmond, R.H. Tredgold and Edel Quinn. Their work appears in journals such as The American Journal of Gastroenterology, The Breast, Journal of Pharmaceutical Sciences, Advanced Drug Delivery Reviews and Clinical Chemistry and Laboratory Medicine (CCLM).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026